A double-blind combination study of clonazepam with sertraline in obsessive-compulsive disorder.

Journal Article

This double blind, randomized, parallel, placebo-controlled study investigates whether clonazepam accelerates and/ or increases the overall response in patients with obsessive compulsive disorder (OCD) who are treated with sertraline. Thirty-seven patients were randomized with 20 in the sertraline and clonazepam group and 17 in the sertraline and placebo groups. Male and female outpatients, age 18-65 years, met criteria for a primary diagnosis of obsessive compulsive disorder according to DSM-IV, as determined by the structured clinical MINI interview. Appropriate safety and efficacy parameters were measured throughout the study. The determination of efficacy was based primarily on changes from baseline to the last observation taken through week 12. Analysis revealed no significant difference between groups at endpoint on the main scale.

Full Text

Duke Authors

Cited Authors

  • Crockett, BA; Churchill, E; Davidson, JRT

Published Date

  • July 1, 2004

Published In

Volume / Issue

  • 16 / 3

Start / End Page

  • 127 - 132

PubMed ID

  • 15517844

Electronic International Standard Serial Number (EISSN)

  • 1547-3325

International Standard Serial Number (ISSN)

  • 1040-1237

Digital Object Identifier (DOI)

  • 10.1080/10401230490486972

Language

  • eng